FdaApplication
ANDA 202807
Identifiers
- fda_app_no: ANDA202807
Properties
| Property | Value |
|---|---|
| applicant_name | CATALENT PHARMA SOLUTIONS LLC |
| application_type | ANDA |
| approval_date | 2019-01-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAPROXEN SODIUM | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE;ORAL |
1 product